检测皮肤药物不良反应的新策略:一个案例系列研究
Erika-Gyöngyi Bán1, Patrick Lechsner1, Eszter-Anna Dho-Nagy1
1Faculty of Medicine in English, Preclinical Research Laboratory, "G.E.Palade" University of Medicine, Pharmacy, Science and Technology Targu Mures (UMFST), 540142 Targu Mures, Romania.
Diagnostics (Basel, Switzerland)
|March 27, 2024
概括
一种新的超声波设备,Dermus SkinScanner-U,在评估皮肤对药物的反应方面表现有前途. 它与患者生活质量得分和药物治疗分析有很好的相关性,有助于诊断不良皮肤药物反应.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 医疗成像医学成像
背景情况:
- 皮肤药物不良反应 (ACDR) 由于多病症的增加而构成越来越大的临床挑战.
- 对皮肤病变的客观评估受到缺乏技术和标准化指导方针的阻碍.
- 患者不遵守药物治疗可能是由于未经管理的皮肤病变造成的.
研究的目的:
- 为了评估新的皮肤皮肤扫描仪-U,一个光学引导的高频超声波成像设备.
- 评估设备与皮肤病生命质量指数 (DLQI) 的可比性.
- 将设备的发现与患者药物治疗的药理学分析进行比较.
主要方法:
- 对40名长期药物使用和皮肤病变的成年患者的评估.
- 使用Dermus SkinScanner-U进行光学引导的高频超声波成像.
- 与DLQI得分和药物治疗分析相关的成像发现.
主要成果:
- 观察到病变的光学和超声波图像特征之间存在显著的相关性.
- 该设备的发现与DLQI得分有显著的相关性.
- 在成像发现和药物治疗的药理学分析之间发现了显著的相关性.
结论:
- 皮肤皮肤扫描仪显示了与药物反应相关的皮肤病变的客观评估的潜力.
- 该设备与已确定的生活质量和药物分析指标具有可比性.
- 进一步的研究将专注于扩大研究规模,以开发一种质量可靠的ACDR诊断方法.
相关概念视频
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K


